65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02199496 (ClinicalTrials.gov)	October 19, 2015	23/7/2014	Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflamma ...	An Open-Label Phase I/II Pilot Study to Assess the Safety/Tolerability and Efficacy of Ustekinumab f ...	Gastrointestinal Inflammation Associated With CVID;CVID Enteropathy	Biological: Stelara (ustekinumab)	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	75 Years	All	5	Phase 1/Phase 2	United States

First Previous1Next Last